​
​

Lumos Pharma Ownership 2024 | Who Owns Lumos Pharma Now?

OverviewForecastRevenueFinancialsChartTranscripts

Institutional Ownership

25.64%

Insider Ownership

34.80%

Retail Ownership

39.56%

Institutional Holders

35.00

Lumos Pharma Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
WELLS FARGO & COMPANY/MN5.12%0.00%414,981-570-0.14%962,755Jun 30, 2024
GOLDMAN SACHS GROUP INC5.02%0.00%406,611-1-0.00%943,338Jun 30, 2024
VANGUARD GROUP INC3.01%-244,082--566,270Jun 30, 2024
RENAISSANCE TECHNOLOGIES LLC2.66%0.00%215,814-2,200-1.01%500,688Jun 30, 2024
ACUITAS INVESTMENTS, LLC1.75%0.18%141,4357460.53%328,129Jun 30, 2024
JEFFERIES FINANCIAL GROUP INC.1.49%0.00%120,651--279,910Jun 30, 2024
LION POINT CAPITAL, LP1.12%0.38%90,794--210,642Jun 30, 2024
GREENWICH WEALTH MANAGEMENT LLC0.94%0.01%76,341--177,000Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC0.63%-50,7273,1316.58%117,708Jun 30, 2024
BLACKROCK INC.0.51%-41,104--95,361Jun 30, 2024
MILLENNIUM MANAGEMENT LLC0.46%-37,018-561-1.49%85,882Jun 30, 2024
PRIVATE ADVISOR GROUP, LLC0.37%0.00%30,01314,00087.43%69,630Jun 30, 2024
DIMENSIONAL FUND ADVISORS LP0.37%-29,587-30-0.10%68,631Jun 30, 2024
BRIDGEWAY CAPITAL MANAGEMENT, LLC0.34%0.00%27,643--64,132Jun 30, 2024
MARQUETTE ASSET MANAGEMENT, LLC0.32%0.01%25,760--59,764Jun 30, 2024
ENVESTNET ASSET MANAGEMENT INC0.24%-19,4753,36020.85%45,182Jun 30, 2024
TWO SIGMA INVESTMENTS, LP0.23%0.00%18,945-19,872-51.19%43,952Jun 30, 2024
BANK OF NEW YORK MELLON CORP0.15%-11,858--27,509Jun 30, 2024
WEALTH ADVISORS OF IOWA, LLC0.14%0.02%11,699--27,142Jun 30, 2024
STATE STREET CORP0.14%-11,237--26,070,000Jun 30, 2024

Lumos Pharma's largest institutional shareholder is WELLS FARGO & COMPANY/MN, holding 5.12% of the company's total share outstanding, currently valued at $962.75K. The top 10 institutional shareholders own together 22.24% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
LION POINT CAPITAL, LP1.12%0.38%90,794--210,642Jun 30, 2024
ACUITAS INVESTMENTS, LLC1.75%0.18%141,4357460.53%328,129Jun 30, 2024
WEALTH ADVISORS OF IOWA, LLC0.14%0.02%11,699--27,142Jun 30, 2024
GREENWICH WEALTH MANAGEMENT LLC0.94%0.01%76,341--177,000Jun 30, 2024
MARQUETTE ASSET MANAGEMENT, LLC0.32%0.01%25,760--59,764Jun 30, 2024
PALADIN ADVISORY GROUP, LLC0.05%0.01%4,387--9,928Jun 30, 2024
KEY FINANCIAL INC0.13%0.01%10,927--25,351Jun 30, 2024
JEFFERIES FINANCIAL GROUP INC.1.49%0.00%120,651--279,910Jun 30, 2024
BRIDGEWAY CAPITAL MANAGEMENT, LLC0.34%0.00%27,643--64,132Jun 30, 2024
REDWOOD WEALTH MANAGEMENT GROUP, LLC0.01%0.00%500500100.00%1,160Jun 30, 2024
RENAISSANCE TECHNOLOGIES LLC2.66%0.00%215,814-2,200-1.01%500,688Jun 30, 2024
PRIVATE ADVISOR GROUP, LLC0.37%0.00%30,01314,00087.43%69,630Jun 30, 2024
WEST FINANCIAL ADVISORS, LLC0.01%0.00%784--1,819Jun 30, 2024
ATRIA INVESTMENTS, INC0.13%0.00%10,80310,803100.00%25,063Jun 30, 2024
WELLS FARGO & COMPANY/MN5.12%0.00%414,981-570-0.14%962,755Jun 30, 2024
GOLDMAN SACHS GROUP INC5.02%0.00%406,611-1-0.00%943,338Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)0.04%0.00%3,58289133.11%8,310Jun 30, 2024
TWO SIGMA INVESTMENTS, LP0.23%0.00%18,945-19,872-51.19%43,952Jun 30, 2024
MILLENNIUM MANAGEMENT LLC0.46%-37,018-561-1.49%85,882Jun 30, 2024
LIVE OAK INVESTMENT PARTNERS0.00%-1111100.00%26Jun 30, 2024

The largest Lumos Pharma shareholder by % of total assets is LION POINT CAPITAL, LP. The company owns 90.79K shares of Lumos Pharma (LUMO), representing 0.38% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
PRIVATE ADVISOR GROUP, LLC0.37%0.00%30,01314,00087.43%69,630Jun 30, 2024
ATRIA INVESTMENTS, INC0.13%0.00%10,80310,803100.00%25,063Jun 30, 2024
ENVESTNET ASSET MANAGEMENT INC0.24%-19,4753,36020.85%45,182Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC0.63%-50,7273,1316.58%117,708Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)0.04%0.00%3,58289133.11%8,310Jun 30, 2024
ACUITAS INVESTMENTS, LLC1.75%0.18%141,4357460.53%328,129Jun 30, 2024
REDWOOD WEALTH MANAGEMENT GROUP, LLC0.01%0.00%500500100.00%1,160Jun 30, 2024
ADVISOR GROUP HOLDINGS, INC.0.00%-310156101.30%720Jun 30, 2024
MORGAN STANLEY0.00%-27711166.87%643Jun 30, 2024
INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC0.00%-3838100.00%88Jun 30, 2024
LIVE OAK INVESTMENT PARTNERS0.00%-1111100.00%26Jun 30, 2024
JONES FINANCIAL COMPANIES LLLP--44100.00%9Jun 30, 2024
QUBE RESEARCH & TECHNOLOGIES LTD--3--7Jun 30, 2024
BANK OF AMERICA CORP /DE/0.02%-1,800--4,176Jun 30, 2024
STATE STREET CORP0.14%-11,237--26,070,000Jun 30, 2024
BLACKROCK INC.0.51%-41,104--95,361Jun 30, 2024
BANK OF NEW YORK MELLON CORP0.15%-11,858--27,509Jun 30, 2024
VANGUARD GROUP INC3.01%-244,082--566,270Jun 30, 2024
WEST FINANCIAL ADVISORS, LLC0.01%0.00%784--1,819Jun 30, 2024
BRIDGEWAY CAPITAL MANAGEMENT, LLC0.34%0.00%27,643--64,132Jun 30, 2024

As of Jun 30 2024, Lumos Pharma's largest institutional buyer is PRIVATE ADVISOR GROUP, LLC. The company purchased 14.00K stocks of LUMO, valued at $69.63K.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
BLACKSTONE INC.----78,624-100.00%-Jun 30, 2024
TWO SIGMA INVESTMENTS, LP0.23%0.00%18,945-19,872-51.19%43,952Jun 30, 2024
UBS GROUP AG----3,733-100.00%-Jun 30, 2024
RENAISSANCE TECHNOLOGIES LLC2.66%0.00%215,814-2,200-1.01%500,688Jun 30, 2024
WELLS FARGO & COMPANY/MN5.12%0.00%414,981-570-0.14%962,755Jun 30, 2024
MILLENNIUM MANAGEMENT LLC0.46%-37,018-561-1.49%85,882Jun 30, 2024
GROUP ONE TRADING, L.P.----150-100.00%-Jun 30, 2024
DIMENSIONAL FUND ADVISORS LP0.37%-29,587-30-0.10%68,631Jun 30, 2024
JPMORGAN CHASE & CO0.00%-13-28-68.29%30Jun 30, 2024
GLOBAL RETIREMENT PARTNERS, LLC----11-100.00%-Jun 30, 2024
GOLDMAN SACHS GROUP INC5.02%0.00%406,611-1-0.00%943,338Jun 30, 2024
LION POINT CAPITAL, LP1.12%0.38%90,794--210,642Jun 30, 2024
WEALTH ADVISORS OF IOWA, LLC0.14%0.02%11,699--27,142Jun 30, 2024
GREENWICH WEALTH MANAGEMENT LLC0.94%0.01%76,341--177,000Jun 30, 2024
MARQUETTE ASSET MANAGEMENT, LLC0.32%0.01%25,760--59,764Jun 30, 2024
PALADIN ADVISORY GROUP, LLC0.05%0.01%4,387--9,928Jun 30, 2024
KEY FINANCIAL INC0.13%0.01%10,927--25,351Jun 30, 2024
JEFFERIES FINANCIAL GROUP INC.1.49%0.00%120,651--279,910Jun 30, 2024
BRIDGEWAY CAPITAL MANAGEMENT, LLC0.34%0.00%27,643--64,132Jun 30, 2024
WEST FINANCIAL ADVISORS, LLC0.01%0.00%784--1,819Jun 30, 2024

As of Jun 30 2024, Lumos Pharma's biggest institutional seller is BLACKSTONE INC.. The company sold -78.62K shares of LUMO, valued at -.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
ATRIA INVESTMENTS, INC0.13%0.00%10,80310,803100.00%25,063Jun 30, 2024
REDWOOD WEALTH MANAGEMENT GROUP, LLC0.01%0.00%500500100.00%1,160Jun 30, 2024
LIVE OAK INVESTMENT PARTNERS0.00%-1111100.00%26Jun 30, 2024
JONES FINANCIAL COMPANIES LLLP--44100.00%9Jun 30, 2024

Lumos Pharma's largest new institutional shareholder by number of shares is ATRIA INVESTMENTS, INC, purchased 10.80K shares, valued at $25.06K, as of undefined.

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
BLACKSTONE INC.----78,624-100.00%-Jun 30, 2024
UBS GROUP AG----3,733-100.00%-Jun 30, 2024
GROUP ONE TRADING, L.P.----150-100.00%-Jun 30, 2024
GLOBAL RETIREMENT PARTNERS, LLC----11-100.00%-Jun 30, 2024

Lumos Pharma's largest sold out institutional shareholder by shares sold is BLACKSTONE INC., sold -78.62K shares, valued at -, as of undefined.

Lumos Pharma Mutual Fund Holders

Name% Total AssetsTotal SharesChange AmountChange %Date
BRIDGEWAY FUNDS INC0.01%26,744-20,000-42.79%Mar 28, 2024
VANGUARD INDEX FUNDS0.00%238,150-50,828-17.59%Mar 31, 2024
FIDELITY CONCORD STREET TRUST0.00%44,400-190-0.43%Feb 29, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS0.00%5,932--Mar 31, 2024
Meeder Funds0.00%119--Mar 31, 2024
Dimensional ETF Trust0.00%3,6993,69592375.00%Jan 31, 2024
DFA INVESTMENT DIMENSIONS GROUP INC0.00%3,556--Jan 31, 2024
Blackstone Alternative Investment Funds0.00%300200200.00%Mar 31, 2024
USAA MUTUAL FUNDS TRUST0.00%562--Jan 31, 2024
Legg Mason Global Asset Management Trust0.00%2,748--Jan 31, 2024
EQ ADVISORS TRUST0.00%245--Mar 31, 2024
iSHARES TRUST0.00%2,356--Mar 31, 2024

Lumos Pharma's largest mutual fund holder by % of total assets is "BRIDGEWAY FUNDS INC", owning 26.74K shares, compromising 0.01% of its total assets.

Lumos Pharma Institutional Ownership Trends

Institutional Holdings Trend

DateHoldingsChange %
30 Jun, 2435-
31 Mar, 2435-5.41%
31 Dec, 233712.12%
30 Sep, 2333-2.94%
30 Jun, 2334-
31 Mar, 2334-8.11%
31 Dec, 223712.12%
30 Sep, 2233-5.71%
30 Jun, 22352.94%
31 Mar, 2234-5.56%
31 Dec, 21369.09%
30 Sep, 2133-5.71%
30 Jun, 2135-
31 Mar, 2135-20.45%
31 Dec, 204425.71%
30 Sep, 2035-14.63%
30 Jun, 2041-8.89%
31 Mar, 2045-

As of 30 Jun 24, 35 institutions are holding Lumos Pharma's shares, representing an increase of 0.00% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
30 Jun, 242,077,959-4.52%
31 Mar, 242,176,429-8.07%
31 Dec, 232,367,466-3.00%
30 Sep, 232,440,6611.96%
30 Jun, 232,393,8107.21%
31 Mar, 232,232,914-7.42%
31 Dec, 222,411,837-5.89%
30 Sep, 222,562,7537.86%
30 Jun, 222,375,895-4.25%
31 Mar, 222,481,432-8.16%
31 Dec, 212,701,890-5.74%
30 Sep, 212,866,344-10.51%
30 Jun, 213,202,820-3.39%
31 Mar, 213,315,233-12.05%
31 Dec, 203,769,5693.70%
30 Sep, 203,634,9862.04%
30 Jun, 203,562,2478.67%
31 Mar, 203,278,022-

Lumos Pharma (LUMO) has 2.08M shares outstanding as of 30 Jun 24, down -4.52% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
30 Jun, 2425.64%3.55%
31 Mar, 2426.86%3.05%
31 Dec, 2329.67%3.32%
30 Sep, 2329.89%3.54%
30 Jun, 2329.05%3.96%
31 Mar, 2327.10%3.27%
31 Dec, 2228.80%3.09%
30 Sep, 2230.55%3.79%
30 Jun, 2228.40%3.22%
31 Mar, 2229.69%2.82%
31 Dec, 2132.42%2.76%
30 Sep, 2134.30%2.55%
30 Jun, 2136.68%2.31%
31 Mar, 2139.86%1.29%
31 Dec, 2055.62%2.90%
30 Sep, 2043.83%2.38%
30 Jun, 2042.96%2.75%
31 Mar, 2039.53%-

As of 30 Jun 24, Lumos Pharma is held by 25.64% institutional shareholders, representing a 3.55% growth compared to 31 Mar 24.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
30 Jun, 241330.00%
31 Mar, 2410-9.09%
31 Dec, 231137.50%
30 Sep, 238-11.11%
30 Jun, 239-10.00%
31 Mar, 2310-47.37%
31 Dec, 2219216.67%
30 Sep, 226-33.33%
30 Jun, 229-
31 Mar, 229-30.77%
31 Dec, 21138.33%
30 Sep, 211233.33%
30 Jun, 219-50.00%
31 Mar, 2118-10.00%
31 Dec, 202066.67%
30 Sep, 2012-25.00%
30 Jun, 2016-62.79%
31 Mar, 2043-

13 institutional shareholders have increased their position in LUMO stock as of 30 Jun 24 compared to 10 in the previous quarter (a 30.00% increase).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
30 Jun, 247-
31 Mar, 24740.00%
31 Dec, 235-54.55%
30 Sep, 231183.33%
30 Jun, 23650.00%
31 Mar, 234-20.00%
31 Dec, 225-37.50%
30 Sep, 228-27.27%
30 Jun, 221183.33%
31 Mar, 226-33.33%
31 Dec, 21912.50%
30 Sep, 218-33.33%
30 Jun, 2112200.00%
31 Mar, 214-66.67%
31 Dec, 20129.09%
30 Sep, 201137.50%
30 Jun, 208-
31 Mar, 20--

7 institutional shareholders have reduced their position in LUMO stock as of 30 Jun 24 compared to 7 in the previous quarter (a 0.00% increase).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
30 Jun, 2435-2,077,959-4.52%25.64%3.55%1330.00%7-
31 Mar, 2435-5.41%2,176,429-8.07%26.86%3.05%10-9.09%740.00%
31 Dec, 233712.12%2,367,466-3.00%29.67%3.32%1137.50%5-54.55%
30 Sep, 2333-2.94%2,440,6611.96%29.89%3.54%8-11.11%1183.33%
30 Jun, 2334-2,393,8107.21%29.05%3.96%9-10.00%650.00%
31 Mar, 2334-8.11%2,232,914-7.42%27.10%3.27%10-47.37%4-20.00%
31 Dec, 223712.12%2,411,837-5.89%28.80%3.09%19216.67%5-37.50%
30 Sep, 2233-5.71%2,562,7537.86%30.55%3.79%6-33.33%8-27.27%
30 Jun, 22352.94%2,375,895-4.25%28.40%3.22%9-1183.33%
31 Mar, 2234-5.56%2,481,432-8.16%29.69%2.82%9-30.77%6-33.33%
31 Dec, 21369.09%2,701,890-5.74%32.42%2.76%138.33%912.50%
30 Sep, 2133-5.71%2,866,344-10.51%34.30%2.55%1233.33%8-33.33%
30 Jun, 2135-3,202,820-3.39%36.68%2.31%9-50.00%12200.00%
31 Mar, 2135-20.45%3,315,233-12.05%39.86%1.29%18-10.00%4-66.67%
31 Dec, 204425.71%3,769,5693.70%55.62%2.90%2066.67%129.09%
30 Sep, 2035-14.63%3,634,9862.04%43.83%2.38%12-25.00%1137.50%
30 Jun, 2041-8.89%3,562,2478.67%42.96%2.75%16-62.79%8-
31 Mar, 2045-3,278,022-39.53%-43---

Lumos Pharma Insider Shareholders Trades

Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Aug 03, 2023McKew John C.officer Chief Scientific OfficerS-SaleSell3,407$3.21$10.92K18,707
Apr 04, 2023McKew John C.officer Chief Scientific OfficerS-SaleSell2,214$3.27$7.24K23,207

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jan 10, 2024Pitukcheewanont Pisit Dukeofficer Chief Medical OfficerSell---10,930
Jan 10, 2024Pitukcheewanont Pisit Dukeofficer Chief Medical OfficerSell29,750$7.69$228.78K-
Jan 10, 2024Pitukcheewanont Pisit Dukeofficer Chief Medical OfficerSell3,333$3.52$11.73K-
Jan 10, 2024Pitukcheewanont Pisit Dukeofficer Chief Medical OfficerSell25,500$3.30$84.15K-
Aug 03, 2023McKew John C.officer Chief Scientific OfficerF-InKindSell1,593$3.28$5.23K22,114
Aug 03, 2023McKew John C.officer Chief Scientific OfficerS-SaleSell3,407$3.21$10.92K18,707
Aug 03, 2023Lawley Lori Dofficer Chief Financial OfficerF-InKindSell229$3.28$751.1211,502
Apr 04, 2023POWERS BRADLEY Jofficer General CounselF-InKindSell342$3.31$1.13K5,989
Apr 04, 2023McKew John C.officer Chief Scientific OfficerF-InKindSell1,036$3.31$3.43K25,421
Apr 04, 2023McKew John C.officer Chief Scientific OfficerS-SaleSell2,214$3.27$7.24K23,207
Apr 04, 2023Lawley Lori Dofficer Chief Financial OfficerF-InKindSell274$3.31$906.9411,231
Apr 04, 2023Hawkins Richard Jdirector, officer Chief Executive OfficerF-InKindSell1,522$3.31$5.04K750,805

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jan 10, 2024Pitukcheewanont Pisit Dukeofficer Chief Medical OfficerSell---10,930
Jan 10, 2024Pitukcheewanont Pisit Dukeofficer Chief Medical OfficerSell29,750$7.69$228.78K-
Jan 10, 2024Pitukcheewanont Pisit Dukeofficer Chief Medical OfficerSell3,333$3.52$11.73K-
Jan 10, 2024Pitukcheewanont Pisit Dukeofficer Chief Medical OfficerSell25,500$3.30$84.15K-
Aug 03, 2023McKew John C.officer Chief Scientific OfficerF-InKindSell1,593$3.28$5.23K22,114
Aug 03, 2023McKew John C.officer Chief Scientific OfficerS-SaleSell3,407$3.21$10.92K18,707
Aug 03, 2023Lawley Lori Dofficer Chief Financial OfficerF-InKindSell229$3.28$751.1211,502
May 12, 2023Zoth Lota S.director-A-AwardBuy3,345$3.42$11.44K3,345
May 12, 2023van Es-Johansson Andirector-A-AwardBuy3,345$3.42$11.44K3,345
May 12, 2023Raffin Thomas A.director-A-AwardBuy3,345$3.42$11.44K3,345
May 12, 2023McCracken Joseph Sdirector-A-AwardBuy3,345$3.42$11.44K3,345
May 12, 2023LALANDE KEVIN M.director-A-AwardBuy3,345$3.42$11.44K3,345
May 12, 2023JOHNSON CHAD ALLENdirector-A-AwardBuy3,345$3.42$11.44K3,345
Apr 04, 2023POWERS BRADLEY Jofficer General CounselF-InKindSell342$3.31$1.13K5,989
Apr 04, 2023McKew John C.officer Chief Scientific OfficerF-InKindSell1,036$3.31$3.43K25,421
Apr 04, 2023McKew John C.officer Chief Scientific OfficerS-SaleSell2,214$3.27$7.24K23,207
Apr 04, 2023Lawley Lori Dofficer Chief Financial OfficerF-InKindSell274$3.31$906.9411,231
Apr 04, 2023Hawkins Richard Jdirector, officer Chief Executive OfficerF-InKindSell1,522$3.31$5.04K750,805
Feb 03, 2023Schuchart Aaronofficer Chief Business OfficerA-AwardBuy12,000$3.52$42.24K12,000
Feb 03, 2023Schuchart Aaronofficer Chief Business OfficerA-AwardBuy1,000$3.52$3.52K5,485

The last insider sell of Lumos Pharma's stock was made by Pitukcheewanont Pisit Duke on Jan 10 2024, selling - shares at - per share (valued at -).

Lumos Pharma Insider Ownership Trends

All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q3 2024-1-
Q1 2024-2-
Q3 2023-3-
Q2 202366100.00%
Q1 2023127171.43%
Q4 20221--
Q3 202241400.00%
Q1 2022105200.00%
Q3 2021253833.33%
Q2 2021117157.14%
Q1 2021129133.33%
Q2 202022--
Q1 20201333.33%
Q3 201913467200.00%
Q2 201953166.67%
Q1 201943133.33%
Q4 20181425.00%
Q3 20184666.67%
Q2 20186--
Q1 201861154.55%

0 total buy trades, and 1 total sell trades (buy/sell ratio of 0.00%) were made by Lumos Pharma's insiders, as of Q3 2024.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q3 2024---
Q1 2024---
Q3 2023-1-
Q2 2023-1-
Q1 2023-1-
Q4 20221--
Q3 20224--
Q1 2022---
Q3 20212212200.00%
Q2 2021---
Q1 2021-7-
Q2 2020---
Q1 2020---
Q3 2019---
Q2 2019---
Q1 2019---
Q4 2018---
Q3 2018-1-
Q2 2018---
Q1 2018---

As of Q3 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Lumos Pharma's stocks.

Lumos Pharma Peer Ownership

TickerCompany
IPSCCentury Therapeutics, Inc.
ERASErasca, Inc.
CSBRChampions Oncology, Inc.
RZLTRezolute, Inc.
SILOSilo Pharma, Inc.
ANEBAnebulo Pharmaceuticals, Inc.
PRDSPardes Biosciences, Inc.
FBRXForte Biosciences, Inc.
STTKShattuck Labs, Inc.
ELYMEliem Therapeutics, Inc.

LUMO Ownership FAQ

Lumos Pharma is owned by institutional shareholders (25.64%), insiders (34.80%), and public (39.56%). The largest institutional shareholder of Lumos Pharma is WELLS FARGO & COMPANY/MN (5.12% of total shares) and the top mutual fund owner is BRIDGEWAY FUNDS INC (0.01% of total shares).

Lumos Pharma's major institutional shareholders are WELLS FARGO & COMPANY/MN, GOLDMAN SACHS GROUP INC, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, and ACUITAS INVESTMENTS, LLC. The top five shareholders own together 17.56% of the company's share outstanding.

As of Jun 2024, there are 35 institutional shareholders of Lumos Pharma.

WELLS FARGO & COMPANY/MN owns 414.98K shares of Lumos Pharma, representing 5.12% of the company's total shares outstanding, valued at $962.76K (as of Jun 2024).

As of Jun 2024, GOLDMAN SACHS GROUP INC holds 406.61K shares of Lumos Pharma (LUMO), compromising 5.02% of the company, valued at $943.34K.

VANGUARD GROUP INC is the third largest holder of Lumos Pharma. The company owns 244.08K of the company's shares outstanding (worth $566.27K).